Public Engagement

See our upcoming events

FB-small

Jenner Institute

Twitter_small

@JennerInstitute

News

Identification of protective antibodies may be key to malaria vaccine

Posted 14/06/2019

A study led by Jenner Investigator Prof Simon Draper has identified the antibodies that may hold the key to creating the first effective vaccine against malaria infection in the blood. The researchers from the Jenner Institute along with partners from five institutions around the world, have identified the human antibodies that prevent the malaria parasite from entering blood cells, which may be key to creating a highly effective malaria vaccination. The results of the study were published today in the journal Cell.

UK Clinical Vaccine Network Conference, 14th June 2019

Posted 22/05/2019
A new conference series by the UK Clinical Vaccine Network will start on 14 June 2019, in Wolfson College, Oxford, co-hosted by Dr Angela Minassian, Principal Investigator at the Jenner Institute. The conference aims to showcase the work of the UK clinical vaccine community and focuses on the future direction and challenges within the vaccine arena. Topics range from correlates of protection, adjuvants and novel delivery methods to global vaccines and vaccine acceptance. There will alsobe a masterclass for trainees and a plenary talk about careers in vaccinology. The conference will cover recent vaccine development in RSV, typhoid, rabies, CMV, and the potential impact of vaccines on antimicrobial resistance, as well as discussion around vaccine uptake and hesitancy. The programme is targeted towards clinical and non-clinical staff alike. 

News Archive

Recent Publications

Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1. Mol Ther Methods Clin Dev, 14, pp. 148-160. Article

Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT. Health Technol Assess, 23 (38), pp. 1-92. Article

Clinical Trials

Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.

If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.

Jenner Institute Podcasts

See all Jenner podcasts

Seminars

Dr Tom Evans: Mathematical modelling of dose responses in vaccine studies, 19/Sep/2019 11:00

All Seminars